Literature DB >> 18069762

Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.

M Vázquez-Vandyck1, S Roman, J L Vázquez, L Huacuja, G Khalsa, R Troyo-Sanromán, A Panduro.   

Abstract

AIM: To identify the anthropometric, metabolic and mood state in hepatitis C virus (HCV)-infected patients from the west of Mexico and to evaluate the effect of Breathwalk (BW), a combination of walking, synchronized breathing and focussed attention, on those patients.
METHODS: In an experimental study, 17 patients with serological and molecular diagnosis of HCV, not receiving pharmacological treatment, were studied. One hour sessions of BW were practiced 3 times at week for six months. Body composition was assessed by electric impedance. Biochemical profiles and insulin resistance (IR) risk was assessed by conventional methods. Mood state was evaluated with specific and open questions at the beginning and at the end of the program.
RESULTS: Seventy percent of patients were overweight or obese, and 77% of the patients presented with IR at the beginning of the study. Improvements were observed at the 3rd mo, and statistically significant differences were recorded at the 6th mo using the fitness score (76 vs 83, P < 0.01), in alanine aminotransferase (ALT) (106 +/- 93 U/L vs 59 +/- 32 U/L, P < 0.01), total bilirubin (0.09 +/- 1 mg/dL vs 0.62 +/- 0.2 mg/dL, P < 0.01), ALT/AST ratio (1.04 vs 0.70, P < 0.01), triglycerides (165 +/- 86 mg/dL vs 124 +/- 49 mg/dL, P < 0.01) and the IR risk (4.0 vs 2.7). Most patients (88%) indicated to feel better at the end of BW (P < 0.01).
CONCLUSION: Breathwalk has an important effect on body composition, lipid profile and liver enzymes. It is also easy, inexpensive and has a beneficial effect on metabolic and mood state in HCV patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18069762      PMCID: PMC4171232          DOI: 10.3748/wjg.v13.i46.6213

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Studies of a targeted risk reduction intervention through defined exercise (STRRIDE).

Authors:  W E Kraus; C E Torgan; B D Duscha; J Norris; S A Brown; F R Cobb; C W Bales; B H Annex; G P Samsa; J A Houmard; C A Slentz
Journal:  Med Sci Sports Exerc       Date:  2001-10       Impact factor: 5.411

2.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

Review 3.  Hepatitis C: a metabolic liver disease.

Authors:  Steven A Weinman; L Maria Belalcazar
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

4.  Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance.

Authors:  Cheng-Yang Tuan; Fahim Abbasi; Cindy Lamendola; Tracey McLaughlin; Gerald Reaven
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

5.  Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances.

Authors:  H Florez; E Ryder; G Campos; V Fernandez; L M Morales; H Valbuena; E Rincón; M E Gómez; X Raleigh
Journal:  Invest Clin       Date:  1999-06       Impact factor: 0.683

6.  Effects of the amount and intensity of exercise on plasma lipoproteins.

Authors:  William E Kraus; Joseph A Houmard; Brian D Duscha; Kenneth J Knetzger; Michelle B Wharton; Jennifer S McCartney; Connie W Bales; Sarah Henes; Gregory P Samsa; James D Otvos; Krishnaji R Kulkarni; Cris A Slentz
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

7.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Authors:  J M Petit; J B Bour; C Galland-Jos; A Minello; B Verges; M Guiguet; J M Brun; P Hillon
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

Review 8.  Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.

Authors:  R P Myers; T Poynard
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.

Authors:  Robert Ross; Ian Janssen; Jody Dawson; Ann-Marie Kungl; Jennifer L Kuk; Suzy L Wong; Thanh-Binh Nguyen-Duy; SoJung Lee; Katherine Kilpatrick; Robert Hudson
Journal:  Obes Res       Date:  2004-05
View more
  5 in total

1.  Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.

Authors:  Donna L White; Peter A Richardson; Mukhtar Al-Saadi; Stephanie J Fitzgerald; Linda Green; Chami Amaratunge; Manvir Anand; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-12-28       Impact factor: 3.199

Review 2.  Genomic medicine in gastroenterology: A new approach or a new specialty?

Authors:  Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

3.  The metabolic syndrome and mind-body therapies: a systematic review.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Nutr Metab       Date:  2011-05-18

4.  Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis C.

Authors:  Kate Hallsworth; Shion Gosrani; Sarah Hogg; Preya Patel; Aaron Wetten; Rachael Welton; Stuart McPherson; Matthew D Campbell
Journal:  BMJ Open Gastroenterol       Date:  2021-03

Review 5.  Hepatitis C Virus, Insulin Resistance, and Steatosis.

Authors:  Dominik Kralj; Lucija Virović Jukić; Sanja Stojsavljević; Marko Duvnjak; Martina Smolić; Ines Bilić Čurčić
Journal:  J Clin Transl Hepatol       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.